SCHEMBL43255

SCHEMBL43255

C1=NN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16534347 0.88
SCHEMBL29889134 0.38
SCHEMBL27825870 0.38
SCHEMBL29612863 0.38
SCHEMBL6559802 0.38
SCHEMBL10715117 0.38
SCHEMBL11401484 0.27
Hydrochloric Acid SCHEMBL72335 0.27
SCHEMBL1629906 0.27
Fluoride Ion SCHEMBL73611 0.27

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5738 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4251216-B1 SELF-REGULATING BIOADHESIVES FOR WET SUBSTRATES UNIV NANYANG TECH (SG) 2026-05-27 EP claimed
EP-4747004-A1 SAMPLE PREPARATION MATRIX, SYSTEM, METHOD OF MAKING, METHOD OF USING, AND KIT COMPRISING MATRIX Life Technologies Corporation (US) 2026-05-27 EP claimed
WO-2026107178-A1 GLOBAL AFFINITY PROFILING OF MOLECULAR INTERACTIONS USING COMPETITIVE ENRICHMENT CORNELL UNIVERSITY (US) 2026-05-21 WO claimed
WO-2026106497-A2 FUNCTIONALIZED CIRCULAR RNA AND METHODS AND INTERMEDIATES FOR THEIR PRODUCTION SIEĆ BADAWCZA ŁUKASIEWICZ – PORT POLSKI OSRODEK ROZWOJU TECHNOLOGII (PL) 2026-05-21 WO claimed
WO-2026097180-A1 CMD LINKERS FOR LABEL-FREE MOLECULAR ANALYSIS, METHODS OF USE AND MANUFACTURE Nicoya Lifesciences Inc. (CA) 2026-05-15 WO claimed
US-20260133187-A1 CMD Linkers for Label-Free Molecular Analysis, Methods of Use and Manufacture NICOYA LIFESCIENCES INC (CA) 2026-05-14 US claimed
US-20260115276-A1 TREATMENT AND/OR PREVENTION OF AN INFECTION BY MONO/DIVALENT AND POLYVALENT ANTIGEN PARTICLE-MEDIATED IMMUNE RESPONSES VACCINVENT GMBH (DE) 2026-04-30 US claimed
US-20260118357-A1 TETRA-FUNCTIONAL CHEMICAL PROBE AND METHOD FOR IDENTIFYING TARGET MEMBRANE PROTEIN FROM LIVING CELL OR LIVING TISSUE BY USING SAID PROBE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2026-04-30 US claimed
US-20260116060-A1 METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE USING GAS BLOWING AGENT SAMSUNG ELECTRONICS CO LTD (KR) 2026-04-30 US claimed
US-20260109733-A1 MULTI-SCALE INTERACTOME PROFILING OF MEMBRANE PROTEINS USING PHOTOCATALYTIC PROXIMITY LABELING UNIV CALIFORNIA (US) 2026-04-23 US claimed
US-6183516-B1 Method for improved bonding of prosthetic devices to bone SULZER ORTHOPEDICS INC. 2001-02-06 US claimed
US-6143725-A FOR TREATING VASCULAR DISEASES SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S) (FR) 2000-11-07 US claimed
EP-0983287-A1 NOVEL GLYCOSYLATED GINKGOLIDE DERIVATIVES, THEIR APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 2000-03-08 EP claimed
US-5919753-A Cross-linking agent NYCOMED IMAGING AS (NO) 1999-07-06 US claimed
WO-1998052959-A1 NOVEL GLYCOSYLATED GINKGOLIDE DERIVATIVES, THEIR APPLICATION AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) 1998-11-26 WO claimed
EP-0815579-A1 BLACK MATRIX IN COLOUR PICTURE TUBES AND METHOD OF PRODUCING THE BLACK MATRIX Samsung Display Devices Co., Ltd. (KR) 1998-01-07 EP claimed
WO-1997027608-A1 BLACK MATRIX IN COLOUR PICTURE TUBES AND METHOD OF PRODUCING THE BLACK MATRIX SAMSUNG DISPLAY DEVICES CO. LTD. (KR) 1997-07-31 WO claimed
EP-0754947-A1 Device with a biologically active substance covalently immobilised through a bifunctional linker on a nitride substrate C.S.E.M. CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA (CH) 1997-01-22 EP claimed
EP-0739163-A1 INACTIVATION OF VIRUSES PRESENT IN BLOOD COMPONENTS USING CHEMICALLY-ACTIVATED COMPOUNDS HEMASURE, INC. (US) 1996-10-30 EP claimed
WO-1995018530-A1 INACTIVATION OF VIRUSES PRESENT IN BLOOD COMPONENTS USING CHEMICALLY-ACTIVATED COMPOUNDS HEMASURE INC. (US) 1995-07-13 WO claimed